Trump moves to revoke hundreds of federal grants awarded to Harvard—a trove of biodata may be lost in the feud

Harvard sues Trump administration over international student ban

Harvard University has sued the Trump administration a second time since the start of the ongoing feud between the university and White House.

May 23, 2025

Vol.51 No.20

By Claire Marie Porter

Cancer Policy

Appeals court removes block on Trump’s anti-union executive order

A three-judge federal appeals court has lifted a lower court order that blocked the federal government from enacting President Trump’s executive order to end collective bargaining by workers at more than a dozen federal agencies.

May 23, 2025

Vol.51 No.20

By Claire Marie Porter

Cancer Policy

Harvard amends lawsuit against Trump administration, includes additional defendants and funding cuts

Harvard University filed an amended lawsuit against the Trump administration, seeking to add two more federal agencies as defendants and to address the administration’s widening efforts to cut the university’s federal funding—now targeting over $2.6 billion and all future grants.

May 16, 2025

Vol.51 No.19

By Claire Marie Porter

Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit

How is the enterprise of cancer research doing after the first 100 days of the Trump administration?

May 09, 2025

Vol.51 No.18

By Paul Goldberg and Jacquelyn Cobb

Cancer Policy

NIH to update policies and practices, halting subawards to foreign entities

In a statement issued on May 1, NIH said it’s immediately halting most new grant awards to foreign partners working in US-led research consortia.

May 09, 2025

Vol.51 No.18

By Claire Marie Porter

Cancer Policy

Scott Gottlieb, Mark McClellan warn of the major challenges created by planned reorganization of FDA

Scott GottliebMark B. McClellanTwo former FDA commissioners—Scott Gottlieb and Mark B. McClellan—warned that the Trump administration’s proposal to restructure FDA by consolidating the different product centers that review drugs, biologics, animal health, tobacco, and medical devices into a single regulatory office would lead to major challenges.

May 09, 2025

Vol.51 No.18

By Jacquelyn Cobb

Trump moves to revoke hundreds of federal grants awarded to Harvard—a trove of biodata may be lost in the feud

YOU MAY BE INTERESTED IN

Harvard sues Trump administration over international student ban

Appeals court removes block on Trump’s anti-union executive order

Harvard amends lawsuit against Trump administration, includes additional defendants and funding cuts

Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit

NIH to update policies and practices, halting subawards to foreign entities

Scott Gottlieb, Mark McClellan warn of the major challenges created by planned reorganization of FDA

Renew today!

Subscriber content

Never miss an issue!

Login

Trump moves to revoke hundreds of federal grants awarded to Harvard—a trove of biodata may be lost in the feud

YOU MAY BE INTERESTED IN

Harvard sues Trump administration over international student ban

Appeals court removes block on Trump’s anti-union executive order

Harvard amends lawsuit against Trump administration, includes additional defendants and funding cuts

Trump administration is removing the mainstays of NCI and the federal government’s cancer programPeer review, registries, and evidence-based patient information take a big hit

NIH to update policies and practices, halting subawards to foreign entities

Scott Gottlieb, Mark McClellan warn of the major challenges created by planned reorganization of FDA

Never miss an issue!

Login

Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit